Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)
Clinical trial NCT00431041 · COMPLETED
Trial details
- NCT number
- NCT00431041
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-02-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.